![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 32220 |
FusionGeneSummary for RRAS2_FHIT |
![]() |
Fusion gene information | Fusion gene name: RRAS2_FHIT | Fusion gene ID: 32220 | Hgene | Tgene | Gene symbol | RRAS2 | FHIT | Gene ID | 22800 | 2272 |
Gene name | RAS related 2 | fragile histidine triad | |
Synonyms | TC21 | AP3Aase|FRA3B | |
Cytomap | 11p15.2 | 3p14.2 | |
Type of gene | protein-coding | protein-coding | |
Description | ras-related protein R-Ras2ras-like protein TC21related RAS viral (r-ras) oncogene homolog 2teratocarcinoma oncogene | bis(5'-adenosyl)-triphosphataseAP3A hydrolasediadenosine 5',5'''-P1,P3-triphosphate hydrolasedinucleosidetriphosphatase | |
Modification date | 20180519 | 20180519 | |
UniProtAcc | P62070 | P49789 | |
Ensembl transtripts involved in fusion gene | ENST00000545643, ENST00000537760, ENST00000414023, ENST00000529237, ENST00000256196, ENST00000534746, ENST00000526063, ENST00000532814, | ENST00000476844, ENST00000492590, ENST00000466788, ENST00000468189, ENST00000341848, | |
Fusion gene scores | * DoF score | 2 X 1 X 2=4 | 17 X 7 X 10=1190 |
# samples | 2 | 20 | |
** MAII score | log2(2/4*10)=2.32192809488736 | log2(20/1190*10)=-2.57288966842058 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: RRAS2 [Title/Abstract] AND FHIT [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation | Oncogene involved fusion gene, in-frame and retained their domain. Tumor suppressor gene involved fusion gene, in-frame but not retained their domain. Tumor suppressor gene involved fusion gene, retained protein feature but frameshift. DDR (DNA damage repair) gene involved fusion gene, in-frame but not retained their domain. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | FHIT | GO:0006163 | purine nucleotide metabolic process | 9323207 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | PRAD | TCGA-KK-A7B3-01A | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000545643 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
In-frame | ENST00000545643 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000545643 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000545643 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000545643 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000537760 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000537760 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000537760 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000537760 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000537760 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000414023 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000414023 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000414023 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000414023 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000414023 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000529237 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000529237 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000529237 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000529237 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000529237 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
In-frame | ENST00000256196 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
In-frame | ENST00000256196 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000256196 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000256196 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
5CDS-5UTR | ENST00000256196 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000534746 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000534746 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000534746 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000534746 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000534746 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000526063 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000526063 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000526063 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000526063 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000526063 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000532814 | ENST00000476844 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-3CDS | ENST00000532814 | ENST00000492590 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000532814 | ENST00000466788 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000532814 | ENST00000468189 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
intron-5UTR | ENST00000532814 | ENST00000341848 | RRAS2 | chr11 | 14380309 | - | FHIT | chr3 | 59908140 | - |
Top |
FusionProtFeatures for RRAS2_FHIT |
![]() |
Hgene | Tgene |
RRAS2 | FHIT |
It is a plasma membrane-associated GTP-binding proteinwith GTPase activity. Might transduce growth inhibitory signalsacross the cell membrane, exerting its effect through an effectorshared with the Ras proteins but in an antagonistic fashion. | Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A)to yield AMP and ADP. Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl) tetraphosphate (Ap4A), but has extremely low activitywith ATP. Modulates transcriptional activation by CTNNB1 andthereby contributes to regulate the expression of genes essentialfor cell proliferation and survival, such as CCND1 and BIRC5.Plays a role in the induction of apoptosis via SRC and AKT1signaling pathways. Inhibits MDM2-mediated proteasomal degradationof p53/TP53 and thereby plays a role in p53/TP53-mediatedapoptosis. Induction of apoptosis depends on the ability of FHITto bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or relatedcompounds, but does not require its catalytic activity, it may inpart come from the mitochondrial form, which sensitizes the low-affinity Ca(2+) transporters, enhancing mitochondrial calciumuptake. Functions as tumor suppressor.{ECO:0000269|PubMed:12574506, ECO:0000269|PubMed:15313915,ECO:0000269|PubMed:16407838, ECO:0000269|PubMed:18077326,ECO:0000269|PubMed:19622739, ECO:0000269|PubMed:8794732,ECO:0000269|PubMed:9323207}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000256196 | - | 1 | 6 | 21_29 | 36 | 205 | Nucleotide binding | Note=GTP |
Tgene | >FHIT | chr11:14380309 | chr3:59908140 | ENST00000341848 | - | 2 | 5 | 94_98 | 93 | 148 | Motif | Histidine triad motif |
Tgene | >FHIT | chr11:14380309 | chr3:59908140 | ENST00000468189 | - | 6 | 9 | 94_98 | 93 | 148 | Motif | Histidine triad motif |
Tgene | >FHIT | chr11:14380309 | chr3:59908140 | ENST00000476844 | - | 6 | 10 | 94_98 | 93 | 214 | Motif | Histidine triad motif |
Tgene | >FHIT | chr11:14380309 | chr3:59908140 | ENST00000492590 | - | 6 | 10 | 94_98 | 93 | 205 | Motif | Histidine triad motif |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000256196 | - | 1 | 6 | 43_51 | 36 | 205 | Motif | Note=Effector region |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000414023 | - | 1 | 5 | 43_51 | -43 | 128 | Motif | Note=Effector region |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000526063 | - | 1 | 6 | 43_51 | -118 | 128 | Motif | Note=Effector region |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000529237 | - | 1 | 6 | 43_51 | -80 | 128 | Motif | Note=Effector region |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000532814 | - | 1 | 6 | 43_51 | -124 | 128 | Motif | Note=Effector region |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000534746 | - | 1 | 6 | 43_51 | -71 | 128 | Motif | Note=Effector region |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000537760 | - | 1 | 6 | 43_51 | -38 | 170 | Motif | Note=Effector region |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000256196 | - | 1 | 6 | 127_130 | 36 | 205 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000256196 | - | 1 | 6 | 157_159 | 36 | 205 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000256196 | - | 1 | 6 | 68_72 | 36 | 205 | Nucleotide binding | GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000414023 | - | 1 | 5 | 127_130 | -43 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000414023 | - | 1 | 5 | 157_159 | -43 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000414023 | - | 1 | 5 | 21_29 | -43 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000414023 | - | 1 | 5 | 68_72 | -43 | 128 | Nucleotide binding | GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000526063 | - | 1 | 6 | 127_130 | -118 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000526063 | - | 1 | 6 | 157_159 | -118 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000526063 | - | 1 | 6 | 21_29 | -118 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000526063 | - | 1 | 6 | 68_72 | -118 | 128 | Nucleotide binding | GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000529237 | - | 1 | 6 | 127_130 | -80 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000529237 | - | 1 | 6 | 157_159 | -80 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000529237 | - | 1 | 6 | 21_29 | -80 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000529237 | - | 1 | 6 | 68_72 | -80 | 128 | Nucleotide binding | GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000532814 | - | 1 | 6 | 127_130 | -124 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000532814 | - | 1 | 6 | 157_159 | -124 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000532814 | - | 1 | 6 | 21_29 | -124 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000532814 | - | 1 | 6 | 68_72 | -124 | 128 | Nucleotide binding | GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000534746 | - | 1 | 6 | 127_130 | -71 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000534746 | - | 1 | 6 | 157_159 | -71 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000534746 | - | 1 | 6 | 21_29 | -71 | 128 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000534746 | - | 1 | 6 | 68_72 | -71 | 128 | Nucleotide binding | GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000537760 | - | 1 | 6 | 127_130 | -38 | 170 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000537760 | - | 1 | 6 | 157_159 | -38 | 170 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000537760 | - | 1 | 6 | 21_29 | -38 | 170 | Nucleotide binding | Note=GTP |
Hgene | >RRAS2 | chr11:14380309 | chr3:59908140 | ENST00000537760 | - | 1 | 6 | 68_72 | -38 | 170 | Nucleotide binding | GTP |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000341848 | - | 2 | 5 | 2_109 | 93 | 148 | Domain | HIT |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000468189 | - | 6 | 9 | 2_109 | 93 | 148 | Domain | HIT |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000476844 | - | 6 | 10 | 2_109 | 93 | 214 | Domain | HIT |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000492590 | - | 6 | 10 | 2_109 | 93 | 205 | Domain | HIT |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000341848 | - | 2 | 5 | 89_92 | 93 | 148 | Nucleotide binding | Substrate |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000468189 | - | 6 | 9 | 89_92 | 93 | 148 | Nucleotide binding | Substrate |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000476844 | - | 6 | 10 | 89_92 | 93 | 214 | Nucleotide binding | Substrate |
Tgene | FHIT | chr11:14380309 | chr3:59908140 | ENST00000492590 | - | 6 | 10 | 89_92 | 93 | 205 | Nucleotide binding | Substrate |
Top |
FusionGeneSequence for RRAS2_FHIT |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_RRAS2_ENST00000545643_chr11_14380309_-_FHIT_ENST00000476844_chr3_59908140_-_91aa MAAAGWRDGSGQEKYRLVVVGGGGVGKSALTIQFIQHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ >In-frame_RRAS2_ENST00000545643_chr11_14380309_-_FHIT_ENST00000492590_chr3_59908140_-_91aa MAAAGWRDGSGQEKYRLVVVGGGGVGKSALTIQFIQHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ >In-frame_RRAS2_ENST00000256196_chr11_14380309_-_FHIT_ENST00000476844_chr3_59908140_-_91aa MAAAGWRDGSGQEKYRLVVVGGGGVGKSALTIQFIQHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ >In-frame_RRAS2_ENST00000256196_chr11_14380309_-_FHIT_ENST00000492590_chr3_59908140_-_91aa MAAAGWRDGSGQEKYRLVVVGGGGVGKSALTIQFIQHVHVHVLPRKAGDFHRNDSIYEELQKHDKEDFPASWRSEEEMAAEAAALRVYFQ |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_RRAS2_ENST00000545643_chr11_14380309_-_FHIT_ENST00000476844_chr3_59908140_-_273nt ATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACCGGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTC ACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTC CAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAG >In-frame_RRAS2_ENST00000545643_chr11_14380309_-_FHIT_ENST00000492590_chr3_59908140_-_273nt ATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACCGGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTC ACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTC CAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAG >In-frame_RRAS2_ENST00000256196_chr11_14380309_-_FHIT_ENST00000476844_chr3_59908140_-_273nt ATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACCGGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTC ACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTC CAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAG >In-frame_RRAS2_ENST00000256196_chr11_14380309_-_FHIT_ENST00000492590_chr3_59908140_-_273nt ATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACCGGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTC ACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGAAGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTC CAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGGAGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAG |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_RRAS2_ENST00000545643_chr11_14380309_-_FHIT_ENST00000476844_chr3_59908140_-_851nt CAGACGGCCATTTGTGGCGGCGCTGGAGGCTGCGTTCGGCAGGCGCTGCGGAGACGCGTAGAGGAGCGCGCCCCCCGGCCGCTGCCGCCC CTGGCCCGTGCCGTCACCCCGCTTCTCCGCGCCTCGGGCGGTACCCAGCCAGTCCCCAGCGCCGCGCTACCGCGCTGACCGGCCCTCCAG ACGCCTCCCGGTACCCGGGACCCCAGCCCGGCCGCTCGCCCGCAGCCCGCCGGCCGCACACGTCCCCGGAGCCGGGCCTAGGGCGGGCGG CAGCGGCGGCTCGGCGCAGTCAGGCTGGGCTCTGTAGCGTCCCCATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACC GGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTCACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGA AGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGG AGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATCCTGAATTCCAGCAAAAGAGCTATTGCCAACCAGTT TGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAAATGCAGTTTCTTCATCTCACCATCCTGTATTCTTCAACCAG TGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAAACGGCTCAGACAGGCAGATTTGAGGTTTCCCCCTGTCTCCT >In-frame_RRAS2_ENST00000545643_chr11_14380309_-_FHIT_ENST00000492590_chr3_59908140_-_862nt CAGACGGCCATTTGTGGCGGCGCTGGAGGCTGCGTTCGGCAGGCGCTGCGGAGACGCGTAGAGGAGCGCGCCCCCCGGCCGCTGCCGCCC CTGGCCCGTGCCGTCACCCCGCTTCTCCGCGCCTCGGGCGGTACCCAGCCAGTCCCCAGCGCCGCGCTACCGCGCTGACCGGCCCTCCAG ACGCCTCCCGGTACCCGGGACCCCAGCCCGGCCGCTCGCCCGCAGCCCGCCGGCCGCACACGTCCCCGGAGCCGGGCCTAGGGCGGGCGG CAGCGGCGGCTCGGCGCAGTCAGGCTGGGCTCTGTAGCGTCCCCATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACC GGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTCACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGA AGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGG AGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATGTTTTTCAGATCCTGAATTCCAGCAAAAGAGCTATT GCCAACCAGTTTGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAAATGCAGTTTCTTCATCTCACCATCCTGTAT TCTTCAACCAGTGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAAACGGCTCAGACAGGCAGATTTGAGGTTTCC >In-frame_RRAS2_ENST00000256196_chr11_14380309_-_FHIT_ENST00000476844_chr3_59908140_-_851nt CAGACGGCCATTTGTGGCGGCGCTGGAGGCTGCGTTCGGCAGGCGCTGCGGAGACGCGTAGAGGAGCGCGCCCCCCGGCCGCTGCCGCCC CTGGCCCGTGCCGTCACCCCGCTTCTCCGCGCCTCGGGCGGTACCCAGCCAGTCCCCAGCGCCGCGCTACCGCGCTGACCGGCCCTCCAG ACGCCTCCCGGTACCCGGGACCCCAGCCCGGCCGCTCGCCCGCAGCCCGCCGGCCGCACACGTCCCCGGAGCCGGGCCTAGGGCGGGCGG CAGCGGCGGCTCGGCGCAGTCAGGCTGGGCTCTGTAGCGTCCCCATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACC GGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTCACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGA AGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGG AGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATCCTGAATTCCAGCAAAAGAGCTATTGCCAACCAGTT TGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAAATGCAGTTTCTTCATCTCACCATCCTGTATTCTTCAACCAG TGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAAACGGCTCAGACAGGCAGATTTGAGGTTTCCCCCTGTCTCCT >In-frame_RRAS2_ENST00000256196_chr11_14380309_-_FHIT_ENST00000492590_chr3_59908140_-_862nt CAGACGGCCATTTGTGGCGGCGCTGGAGGCTGCGTTCGGCAGGCGCTGCGGAGACGCGTAGAGGAGCGCGCCCCCCGGCCGCTGCCGCCC CTGGCCCGTGCCGTCACCCCGCTTCTCCGCGCCTCGGGCGGTACCCAGCCAGTCCCCAGCGCCGCGCTACCGCGCTGACCGGCCCTCCAG ACGCCTCCCGGTACCCGGGACCCCAGCCCGGCCGCTCGCCCGCAGCCCGCCGGCCGCACACGTCCCCGGAGCCGGGCCTAGGGCGGGCGG CAGCGGCGGCTCGGCGCAGTCAGGCTGGGCTCTGTAGCGTCCCCATGGCCGCGGCCGGCTGGCGGGACGGCTCCGGCCAGGAGAAGTACC GGCTCGTGGTGGTCGGCGGGGGCGGCGTGGGCAAGTCGGCGCTCACCATCCAGTTCATCCAGCACGTTCACGTCCATGTTCTTCCCAGGA AGGCTGGAGACTTTCACAGGAATGACAGCATCTATGAGGAGCTCCAGAAACATGACAAGGAGGACTTTCCTGCCTCTTGGAGATCAGAGG AGGAAATGGCAGCAGAAGCCGCAGCTCTGCGGGTCTACTTTCAGTGACACAGATGTTTTTCAGATCCTGAATTCCAGCAAAAGAGCTATT GCCAACCAGTTTGAAGACCGCCCCCCGCCTCTCCCCAAGAGGAACTGAATCAGCATGAAAATGCAGTTTCTTCATCTCACCATCCTGTAT TCTTCAACCAGTGATCCCCCACCTCGGTCACTCCAACTCCCTTAAAATACCTAGACCTAAACGGCTCAGACAGGCAGATTTGAGGTTTCC |
Top |
FusionGenePPI for RRAS2_FHIT |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
RRAS2 | LGALS4, XRCC6, RAF1, PIK3R1, RALGDS, RIN1, MLLT4, CDK2, PAN2, TRAF2, CREB3, ARAF, CCDC8, RABGGTB, FNTB, DBN1, SNCA, TSNAX, SYNPO, LIMA1, FOXS1 | FHIT | FHIT, UBE2I, CTNNB1, LEF1, TRIM23, RAB40B, MDM2, REL, TP53, ARHGAP19, MTMR6, RABL2A, CHEK1 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for RRAS2_FHIT |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | FHIT | P49789 | DB04173 | Fructose | Bis(5'-adenosyl)-triphosphatase | small molecule | approved|experimental |
Top |
RelatedDiseases for RRAS2_FHIT |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | RRAS2 | C0023904 | Liver Neoplasms, Experimental | 1 | CTD_human |
Hgene | RRAS2 | C0349639 | Juvenile Myelomonocytic Leukemia | 1 | CTD_human |
Tgene | FHIT | C0024121 | Lung Neoplasms | 2 | CTD_human |
Tgene | FHIT | C0025500 | Mesothelioma | 2 | CTD_human |
Tgene | FHIT | C0007131 | Non-Small Cell Lung Carcinoma | 1 | CTD_human |
Tgene | FHIT | C0023903 | Liver neoplasms | 1 | CTD_human |
Tgene | FHIT | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | FHIT | C0036341 | Schizophrenia | 1 | PSYGENET |
Tgene | FHIT | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Tgene | FHIT | C0042076 | Urologic Neoplasms | 1 | CTD_human |
Tgene | FHIT | C0236733 | Amphetamine-Related Disorders | 1 | CTD_human |
Tgene | FHIT | C0236969 | Substance-Related Disorders | 1 | CTD_human |